Coagulation Cascade in Hemostasis & Thrombosis: Pathways & Mechanisms

Taking a closer look: Ischemic stroke and the coagulation cascade

87% of all strokes in the US are ischemic.² And when you consider that 1 in 5 stroke survivors will have a secondary stroke within 5 years, it’s important to understand the processes that contribute to risk.^3,4

The coagulation cascade plays a central role in ischemic stroke, where pathologic thrombus formation within cerebral arteries leads to vessel occlusion and downstream ischemia.⁵

A thorough understanding of the coagulation cascade and its pathways is helpful to grasp how hemostasis may be uncoupled from thrombosis.⁶ This mechanism may help to prevent pathological clot formation while leaving hemostasis intact.

Diagram showing the extrinsic, intrinsic, and common coagulation pathways leading to thrombin generation, with a thrombin amplification loop.

FVIIa, activated factor VII; FXa, activated factor X; FXI, factor XI; FXIa, activated factor XI; FXIIa, activated factor XII; TF, tissue factor.

Different clotting factors have different roles in pathologic thrombosis and bleeding potential¹

The coagulation cascade operates at the intersection of normal hemostasis and pathologic thrombosis¹
Some factors are critical for maintaining normal clotting, whereas others—particularly within the extrinsic pathway—appear to play a greater role in thrombus propagation than in bleeding potential¹

Bleeding potential and the connection to thrombin generation and fibrin stability

Inherited deficiencies of coagulation factors produce highly variable bleeding patterns⁸
Clinical severity of bleeding depends less on pathway position and more on the factorʼs contribution to thrombin generation and fibrin stability⁷

Chart categorizing coagulation factors by severe, variable, minimal or no bleeding potential, with factors grouped by extrinsic, intrinsic, and common pathways.

FV, factor V; FVII, factor II; FVIII, factor VIII; FIX, factor XI; FXII, factor XII.

Understanding the coagulation cascade and its pathways can help us appreciate how hemostasis may be uncoupled from thrombosis.

Illustration of 4 outlined people with text: Up to 1 in 4 people in the US over the age of 25 will suffer a stroke in their lifetime (up to 1 in 5 will suffer an ischemic stroke).

Burden of stroke

Challenges in secondary stroke prevention result in high rates of recurrence. How many of your patients are vulnerable to another stroke?

Learn more

Abstract visual with a purple brain illustration, question mark, and exclamation point.

Test your stroke knowledge

How do you compare with your peers? Test your knowledge of stroke epidemiology and pathophysiology in the stroke epidemiology quiz.

Take the quiz

Top view of 5 healthcare professionals in green and purple scrubs standing together and reviewing documents.

Get connected with Bayer

Stay up to date with more information.

Reference

Smith SA, et al. Crit Rev Biochem Mol Biol. 2015;50(4):326-336.
Martin SS, et al. Circulation. 2024;149(8):e347-e913.
Kolmos M, et al. J Stroke Cerebrovasc Dis. 2021;30(8):105935.
Lakshminarayan K, et al. Stroke. 2011;42(6):1556-1562.
Kuriakose D, et al. Int J Mol Sci. 2020;21(20):7609.
Raffo C, et al. Euro Heart J Suppl. 2025;27(Suppl 3):iii46-iii53.
Hoffman M, et al. Thromb Haemost. 2001;85(6):958-965.
Peyvandi F, et al. J Thromb Haemost. 2012;10(4):615-621.
Mann KG, et al. Arterioscler Thromb Vasc Biol. 2003;23(1):17-25.
Mosesson MW. J Thromb Haemost. 2005;3(8):1894-1904.
Casini A, et al. Semin Thromb Hemost. 2016;42(4):366-374.
Mannucci PM, et al. N Engl J Med. 2001;344(23):1773-1779.
Mariani G, et al. Blood. 2005;106(28):2681-2686.
Thalji N, et al. Semin Thromb Hemost. 2013;39(6):607-612.
Camire RM, et al. J Thromb Haemost. 2009;7(12):1951-1961.
Duga S, et al. Semin Thromb Hemost. 2009;35(4):416-425.
Bolton-Maggs PHB. Hematology Am Soc Hematol Educ Program. 2009:97-105.
Salomon O, et al. Blood. 2008;111(8):4113-4117.
Gailani D, et al. Arterioscler Thromb Vasc Biol. 2007;27(12):2507-2513.

Hemostasis & thrombosis